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Abstract
Background: Tight junctions are required for epithelial barrier formation and participate in the
regulation of signalling mechanisms that control proliferation and differentiation. ZO-1 is a tight
junction-associated adaptor protein that regulates gene expression, junction assembly and epithelial
morphogenesis. We have previously demonstrated that the heat shock protein Apg-2 binds ZO-1
and thereby regulates its role in cell proliferation. Here, we addressed the question whether Apg-
2 is also important for junction formation and epithelial morphogenesis.
Results: We demonstrate that depletion of Apg-2 by RNAi in MDCK cells did not prevent
formation of functional tight junctions. Similar to ZO-1, however, reduced expression of Apg-2
retarded de novo junction assembly if analysed in a Ca-switch model. Formation of functional
junctions, as monitored by measuring transepithelial electrical resistance, and recruitment of tight
and adherens junction markers were retarded. If cultured in three dimensional extracellular matrix
gels, Apg-2 depleted cells, as previously shown for ZO-1 depleted cells, did not form hollow
polarised cysts but poorly organised, irregular structures.
Conclusion: Our data indicate that Apg-2 regulates junction assembly and is required for normal
epithelial morphogenesis in a three-dimensional culture system, suggesting that Apg-2 is an
important regulator of epithelial differentiation. As the observed phenotypes are similar to those
previously described for ZO-1 depleted cells and depletion of Apg-2 retards junctional recruitment
of ZO-1, regulation of ZO-1 is likely to be an important functional role for Apg-2 during epithelial
differentiation.
Background
Epithelial tight junctions are the most apical component
of the junctional complex and are critical for epithelial
barrier function as they form the paracellular diffusion
barrier [1-3]. Tight junctions are composed of several
transmembrane proteins that are linked to a cytoplasmic
plaque and the actin cytoskeleton [4,5]. This cytoplasmic
plaque consists of a protein network formed by adaptor
proteins with multiple protein/protein interaction motifs,
cytoskeletal linkers and signalling proteins such as protein
kinases and phosphatases [6,7]. These junction associated
protein complexes also interact with dual localisation pro-
teins that localise to both the junction and the nucleus [8].
Several of these junctional components have been linked
to the regulation of epithelial proliferation, differentia-
tion and polarisation [9,10].
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tions as a junctional adaptor that interacts with multiple
transmembrane proteins, components of the junctional
plaque and actin filaments [4,5,11,12]. ZO-1 is expressed
by most cells and, in the absence of tight junctions, can
associate with other cell-cell adhesion complexes, such as
adherens and gap junctions [13-15]. Repression of ZO-1
expression in different epithelial cell lines revealed that
ZO-1 is not required for junction formation and polarisa-
tion in two-dimensional (2-D) culture systems [16,17]. In
three-dimensional cultures (3-D), however, normal ZO-1
expression is required for the formation of polarised hol-
low cysts, indicating that it plays a role in the regulation
of epithelial morphogenesis [18].
ZO-1 has been directly associated with a signalling func-
tion of tight junctions. ZO-1 binds with its SH3 domain
to the Y-box transcription factor ZONAB (DbpA), which
results in cytoplasmic sequestration and inhibition of the
transcriptional activity of the latter protein [19]. The ZO-
1/ZONAB pathway regulates epithelial proliferation and
expression of genes important for epithelial differentia-
tion and cell cycle progression such as erbB-2, cyclin D1
and PCNA [18-20]. The SH3 domain of ZO-1 also inter-
acts with the heat shock protein Apg-2 [21]. Apg-2 and
ZONAB compete for binding to ZO-1, resulting in
ZONAB dissociation and activation if the interaction with
Apg-2 is favoured by conditions such as, for example, heat
shock. Expression of all three proteins can be deregulated
in different epithelial cancers, suggesting that they might
be functionally relevant for the maintenance of the epi-
thelial cell type and tumorigenesis [22-30].
Given the modulatory role of ZO-1 during junction for-
mation, its involvement in large protein complexes, and
the role of heat shock proteins as folding and assembly
factors, we tested whether Apg-2 regulates junction forma-
tion. Our data indicate that Apg-2 is not essential for the
formation of functional tight junctions but regulates junc-
tion assembly in 2-D cultures similar to its interaction
partner ZO-1. In 3-D cultures, however, Apg-2 was
required for normal epithelial morphogenesis, suggesting
that the heat shock protein regulates pathways important
for epithelial polarisation and differentiation.
Results
Apg-2 regulates the assembly of functional tight junctions
Apg-2 binds to the SH3 domain of ZO-1, and this domain
is important for the regulation of junction assembly in
MDCK cells [16,21]. To test whether Apg-2 is also
required for junction formation, we made use of previ-
ously described MDCK cell lines permitting the condi-
tional depletion of either Apg-2 or ZO-1 [18,21]. In these
cell lines, RNA interference is induced by the addition of
tetracycline, which inactivates a co-transfected repressor,
resulting in expression of shRNAs. We made use of four
different cell lines: two expressing two different shRNA
constructs that target different sequences of Apg-2 (z2 and
z5; [21]), one for the repression of ZO-1 [18], and a con-
trol cell line expressing a non-targeting construct.
To determine possible effects on junction formation, we
combined these cell lines with a calcium-switch protocol,
permitting us to study synchronised de novo junction for-
mation [31]. To do this, cells were plated at high density
on permeable supports, which facilitate the functional
analysis of tight junctions [32], in medium containing a
low calcium concentration, which does not allow the for-
mation of intercellular junctions. 24 hours later, junction
formation was stimulated by changing the medium to
standard culture medium. RNA interference was induced
by adding tetracycline at the time of plating. Figure 1 con-
firms that tetracycline induced depletion of ZO-1 and
Apg-2 in the respective cell lines, but not in control cells.
Depletion of Apg-2 did not significantly affect the expres-
sion of ZO-1 or of the interacting proteins ZO-2 and ZO-
3 (Fig. 1). Similarly, no differences in the expression of
occludin and claudin-4 were observed (not shown).
We next monitored the assembly of functional tight junc-
tions by measuring transepithelial electrical resistance
(TER) at different times after adding calcium. Figure 2A
shows that tetracycline did not affect the assembly of tight
junctions: with and without the antibiotic, cultures
reached maximal TER within about 12 hours (maximal
TER values were between 200 and 240 Ωcm2). TER then
decreased again to about 60% of maximal values after 24
hours. After 2 days, cells reached steady state values of
about 60 Ωcm2. This is the typical profile of TER develop-
ment that has previously been described for MDCK strain
II cells [31].
Figure 2B shows that depletion of ZO-1 resulted in the
previously described retardation of junction formation
[16,17]. TER developed more slowly and only reached
50% of the value of control cultures after 12 hours. After
24 hours, however, the values of depleted and non-
depleted cultures were the same. If Apg-2 was depleted,
TER development was also retarded and cultures reached
about 60% of the value of control cultures after 12 hours
(Fig. 2C and 2D). As in cells with reduced ZO-1 expres-
sion, the TER values measured in depleted and non-
depleted cultures were the same after 24 hours. Similarly,
all cell lines reached steady state values of about 60 Ωcm2
after 2 days. Thus, normal expression of Apg-2, like ZO-1,
is not required for the formation of electrically resistant
tight junctions, but the heat shock protein regulates the
kinetics of junction formation. Normal expression levels
of Apg-2 seem to be sufficient to support efficient junctionPage 2 of 13
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ment of TER in a calcium switch (not shown).
Tight junctions restrict paracellular permeability of ions as
well as of hydrophilic molecules based on their size. As
the two parameters are not always regulated in the same
way, we measured paracellular permeability of fluorescent
dextrans in steady state cultures. Cultures were incubated
for 3 hours with 4 kD or 70 kD fluorescent dextran and
diffusion in the apical-to-basolateral direction was then
determined by measuring fluorescence in the basolateral
medium. Figure 2E shows that neither depletion of ZO-1
nor Apg-2 affected paracellular permeability of 4 kD dex-
tran. We could also not detect an effect on 70 kD dextran
diffusion (not shown). Thus, Apg-2- and ZO-1-depleted
cells assembled junctions that represented functional
paracellular diffusion barriers.
Depletion of Apg-2 retards the recruitment of ZO-1 and 
interacting proteins
We next tested whether inhibition of TER development
reflected a retardation of junction formation that was
detectable by immunofluorescence. Hence, we fixed cells
after different periods of time with calcium and then
monitored the distribution of Apg-2 and junctional mark-
ers by immunofluorescence. Figure 3A shows that Apg-2
was present in the nucleus as well as the cytoplasm of con-
trol cells at all times. As described previously, weak Apg-2
staining was also observed along the lateral membrane
[21]. This appeared to be more evident during early time
points (e.g., 1 and 2 hours). However, this does not
appear to reflect increased association with ZO-1, as we
could not detect preferential co-immunoprecipitation
during junction formation as opposed to stable monolay-
ers (not shown). In depleted cells, expression was low as
expected from the immunoblots in figure 1.
We next analysed the distribution of ZO-1. In control
cells, ZO-1 was quickly recruited to the forming junctional
complex and formed complete junctional rings within 1
hour (Fig. 3B). In contrast, Apg-2 depletion inhibited
junctional recruitment of ZO-1, and junctional rings were
only complete after 2 hours (Fig. 3B and 4A). This inhibi-
tion is unlikely to reflect changes in the organisation of
the actin cytoskeleton, as we could not detect obvious dif-
ferences in the formation of cortical actin belts between
control and Apg-2 depleted cells (Fig. 3C and 4B). How-
ever, it cannot be excluded that reduced Apg-2 expression
caused more subtle changes in actin organisation. Thus,
Apg-2 regulates the junctional recruitment of ZO-1 with-
out strongly affecting the actin cytoskeleton.
We next determined effects on the recruitment of occludin
and claudin-4, two transmembrane components of tight
junctions [4,33]. Figure 5A shows that occludin concen-
trated more slowly at the forming junctional complex in
Apg-2 depleted cells. Similarly, ZO-2 and ZO-3 were also
recruited more slowly (not shown). Claudin-4, however,
was more broadly distributed over the plasma membrane
at early time points and there were no significant differ-
ences between control and depleted cell (Fig. 4B and 5B).
Cingulin, a protein known to interact with ZO-1 [34], was
also recruited more slowly to the forming junctions (Fig.
4B and 5C) whereas GEF-H1, which interacts with cingu-
lin [35], was recruited only later to tight junctions even in
control cells, and no differences were observed in Apg-2
depleted cells (Fig. 4B and 5D).
ZO-1 depletion has also been associated with a retarda-
tion in the maturation of adherens junctions from spot-
like to belt-like junctions [36]. Hence, we tested whether
Apg-2-depletion influenced the junctional recruitment of
the adherens junction markers α-catenin, which is known
Repression of Apg-2 and ZO-1 by regulated RNA interfer-enceFigure 1
Repression of Apg-2 and ZO-1 by regulated RNA 
interference. Stable MDCK cell lines expressing the tetra-
cycline repressor as well as shRNAs targeting ZO-1 or Apg-2 
(z2 and z5 target different sequences), or a non-targeting 
shRNA under the control of a tetracycline-regulated pro-
moter were plated in low calcium medium onto permeable 
culture inserts in the presence or absence of tetracycline. 
After 18 hours, the cells were switched to normal calcium 
medium for 24 hours adding tetracycline as indicated. The 
cells were then lysed in SDS-PAGE sample buffer and ana-
lysed by immunoblotting. Shown are immunoblots for Apg-2, 
ZO-1, ZO-2, ZO-3 and α-tubulin. Expression of ZO-1 was 
reduced to 24 +/- 7% and of Apg-2 to 22 +/- 6% of the 
respective levels in control cultures (n = 4).Page 3 of 13
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Development of functional tight junctionsFigure 2
Development of functional tight junctions. (A-D) Cells were plated and incubated without or with tetracycline as 
described in figure 1. After switching from low calcium to normal calcium medium, TER was measured at the indicated time 
points. Shown is a typical experiment using a control RNAi cell line (A), a ZO-1 RNAi cell line (B), and two Apg-2 RNAi cell 
lines (C and D). Values represent means +/- 1 SD of quadruplicates. (E) Paracellular permeability of fluorescent dextran was 
measured in the same cultures as those shown in panels A to D 3 days after the initiation of junction formation. Shown are the 
values obtained with 4 kD FITC dextran with tetracycline-treated cultures. Values represent means +/- 1 SD of quadruplicates. 
Diffusion of 70 kD dextran was also not affected by depletion of Apg-2 and ZO-1 (not shown).
BMC Cell Biology 2007, 8:49 http://www.biomedcentral.com/1471-2121/8/49to interact with ZO-1 [37,38], and E-cadherin. Indeed, α-
catenin was recruited more slowly and E-cadherin
required more time to form belt-like junctions (Fig. 4B, 5E
and 5F). Thus, Apg-2 depletion retards tight junction for-
mation as well as maturation of adherens junctions.
At later time points, the junctional distribution of tight
and adherens junction markers was the same in Apg-2
depleted and non depleted cells. We could also not detect
any differences in the Triton X-100 insolubility of differ-
ent junctional proteins (not shown). Together with the
functional data in figure 2, this suggests that Apg-2 is not
required for junction formation but functions as a regula-
tor.
Apg-2 is required for epithelial morphogenesis in 3-D 
cultures
Apg-2 regulates signalling by ZO-1 and ZONAB, and both
proteins have been associated with the regulation of epi-
thelial morphogenesis of MDCK cells cultured in extracel-
lular matrix gels [18,21]. Hence, we next tested whether
Apg-2 depletion affected the capability of MDCK cells to
form polarised hollow cysts in 3-D cultures.
Control cells and Apg-2 RNAi cell lines were cultured
without or with tetracycline for 7 days and were then ana-
lyzed by phase contrast microscopy (Fig. 6) and immun-
ofluorescence (Fig. 7). Tetracycline did not affect the
capability of control cells to form polarised cysts as previ-
ously reported [18]. Apg-2 depleted cells, however, did
not form regular structures and most of the cysts did not
contain an obvious lumen. This was confirmed by count-
ing the number of cysts formed by the different cultures:
more than 70% of cysts formed by control cells or by Apg-
2 RNAi cell lines in the absence of tetracycline formed
cysts with a single lumen, but less than 10% did so when
Apg-2 was depleted (Fig. 8).
Retardation of ZO-1 recruitment to forming junctions by Apg-2 depletionFigure 3
Retardation of ZO-1 recruitment to forming junctions by Apg-2 depletion. Control and Apg-2 RNAi cell lines were 
cultured in low calcium with tetracycline and junction formation was then induced for the indicated periods of time before fix-
ation. The cells were then labelled with antibodies against Apg-2 (A), ZO-1 (B), or fluorescent phalloidin (C). If tetracycline was 
not added and Apg-2 was not depleted, Apg-2 RNAi cell lines formed junctions at the same speed as control RNAi cell lines 
(not shown). Note, recruitment of ZO-1 to the forming junctional complex was retarded, but the distribution of ZO-1 
appeared to be normal at later time points.Page 5 of 13
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depleted cells did not achieve the normal polarised organ-
isation. Whereas control cells formed a strong actin ring
along the internal lumen, marking the apical pole of the
cells; Apg-2 depleted cells had the strongest actin labelling
along the external surface of cysts or in irregular internal
structures (Fig. 7). Similarly, the Golgi apparatus was situ-
ated between the nuclei and the lumen in the control
cells; in Apg-2 depleted cells, however, the Golgi appara-
tus was often detected between the nuclei and the external
surface of the cysts (Fig. 7). Immunofluorescence experi-
ments further showed that neither the apical marker
podocalyxin nor not the basolateral plasma membrane
protein erbB-2 achieved their normal polarised expression
in Apg-2 as well as ZO-1 depleted cells (Fig. 9A and 9B).
Staining for junctional markers such as occludin, ZO-1
and β-catenin also suggested that cells with reduced
expression of Apg-2 or ZO-1 failed to form well-organised
polarised cysts (Fig. 9). Thus, Apg-2 is required for the for-
mation of polarised hollow epithelial cysts in 3-D cul-
tures.
Discussion
Tight junctions are composed of multimeric protein com-
plexes often formed by different types of proteins that
interact with each other. Epithelial junction formation is
a sequential process that starts with the formation of a pri-
mordial adhesive junction that then matures into distinct
tight and adherens junctions. ZO-1 can interact with dif-
ferent components of tight and adherens junctions and
appears to play a modulatory role during formation of
both types of junctions [16,17,36]. ZO-1 also regulates
gene expression, cell proliferation and epithelial morpho-
genesis [18-20]. ZO-1's role in gene expression is regu-
lated by an interaction with the heat shock protein Apg-2
[21]. Here we show that Apg-2 also modulates junction
formation and is required for normal epithelial morpho-
genesis in 3-D cultures.
Depletion of Apg-2 affects junction formation in a similar
way as depletion of ZO-1: formation of functional junc-
tions was retarded, but not prevented, and the inhibition
was only modest. In the case of ZO-1, it seems that its
function in tight junction formation is at least in part
redundant as depletion of ZO-2 in ZO-1 knockout cells
prevents tight junction formation [39]. Whether MDCK
cells express other proteins with a similar function as Apg-
2 is currently not known; however, it is conceivable that
other heat shock proteins might also aid junction forma-
tion. Alternatively, it could be that Apg-2 functions as a
catalyst; hence, its function is not required, but its pres-
ence accelerates junction formation.
The mechanism by which Apg-2 regulates junction assem-
bly is not known. It could be that Apg-2 regulates forma-
tion of ZO-1 complexes. We have thus far not been able,
however, to detect differences in proteins co-precipitating
with ZO-1 if Apg-2 was depleted (KM and MSB, unpub-
lished). Nevertheless, it is possible that this involves inter-
Quantification of junction formationFigure 4
Quantification of junction formation. Control and Apg-
2 RNAi cells were cultured and processed as described in fig-
ure 3. Junction formation was allowed to proceed for the 
indicated amount of time (A) or for one hour (B). The cells 
were then stained for either ZO-1 (A) or f-actin, occludin, 
claudin-4, cingulin, GEF-H1, α-catenin or E-cadherin (B). The 
fractions of cells expressing the labelled markers along the 
entire lateral cell membrane were then determined by count-
ing. At least five different fields derived from two independ-
ent experiments were counted for each marker and time 
point. Note, as a large fraction of claudin-4 is continuously at 
the plasma membrane even before the addition of calcium, its 
early presence at the plasma membrane does not indicate 
tight junction formation.Page 6 of 13
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Retardation of junction formation by Apg-2 depletionFigure 5
Retardation of junction formation by Apg-2 depletion. Control and Apg-2 RNAi cell lines were cultured and processed 
as in figure 3 and then stained with antibodies against the transmembrane proteins occludin (A) and claudin-4 (B), the junctional 
plaque components cingulin (C) and GEF-H1 (D), and the adherens junction proteins α-catenin (E) and E-cadherin (F). Shown 
are images derived from samples fixed after 1 hour and 27 hours of junction formation. Note, retardation of junctional recruit-
ment was observed for occludin, cingulin, α-catenin and E-cadherin. GEF-H1 became only concentrated at tight junctions after 
longer time points of junction formation. Claudin-4 was present at the plasma membrane at all time points but only appeared 
to be concentrated at junctions at later time points. GEF-H1 and claudin-4 distributions were not affected by depletion of Apg-
2.
BMC Cell Biology 2007, 8:49 http://www.biomedcentral.com/1471-2121/8/49actions that are not detergent resistant or other unknown
proteins. We could also not detect clear differences in the
Triton X-100 insolubility of junctional proteins between
control and Apg-2 depleted cells, but there was only a
small pool of insoluble proteins at early time points when
junction formation was inhibited (not shown). As we
have only observed kinetic differences in junction forma-
tion, minor quantitative changes in complex formation
might be involved that would be difficult to assess exper-
imentally.
The SH3 domain of ZO-1, which is the domain that inter-
acts with Apg-2, is not only required but also sufficient to
rescue junction formation in ZO-1 depleted MDCK cells
[16,21]. However, the SH3 domain by itself remains in
the cytosol and is not recruited to cell junctions [18,19],
suggesting that it binds to a cellular factor that does not
need to be recruited to junctions. One such factor is the
transcription factor ZONAB; however, neither overexpres-
sion nor depletion of ZONAB affects tight junction forma-
tion (KM and MSB, unpublished) [16]. Hence, one
possibility is that ZO-1 regulates a function of Apg-2
rather than the other way around. In fact, ZO-1 does not
bind the peptide-binding domain of Apg-2 but to the N-
terminal domain containing the ATPase. Hence, ZO-1
binding might affect yet to be discovered functional prop-
erties of Apg-2 such as, for example, release of another
protein bound to the peptide-binding domain. It will
therefore be important to analyse how ZO-1 binding
affects the biochemical properties of Apg-2 and to search
for Apg-2 substrates and other interacting proteins.
Apg-2 also regulates epithelial morphogenesis in 3-D cul-
tures. Apg-2 depleted cells did not form hollow cysts but
poorly organised structures with none or several small
lumen. The disorganised nature of these structures was
evident from different immunofluorescence labellings
that showed that their cells did not possess a uniform
polarity or, in the absence of a clear lumen, maintained
apical markers at the outer surface of the cysts. Strikingly,
we observed the same phenotype in cells depleted of ZO-
1. As overexpression of ZONAB also caused a similar phe-
notype, we considered it as likely that the reduced expres-
sion of ZO-1 affected morphogenesis by stimulating
ZONAB [18]. Apg-2 depletion, however, does not stimu-
late ZONAB but inhibits it, as the two proteins compete
with each other for binding to the SH3 domain of ZO-1
[21]. However, it is possible that deregulation, and not
just activation, of the ZO-1/ZONAB pathway causes
defects in the development of polarised hollow cysts.
Apg-2 depletion inhibits the formation of regular cysts in 3-D culturesFigure 6
Apg-2 depletion inhibits the formation of regular cysts in 3-D cultures. Control and Apg-2 RNAi cell lines were cul-
tured without or with tetracycline in collagen/matrigel gels. The cells were regularly inspected by phase contrast microscopy to 
monitor cyst and lumen formation. The shown images were taken 7 days after the cultures had been started. Note, most cysts 
formed by Apg-2 depleted cells had an irregular shape and lacked a lumen.Page 8 of 13
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that is important for morphogenesis. Moreover, Apg-2 is
expressed in different subcellular locations and, like other
heat shock proteins, might bind many different proteins
and, hence, regulate different types of processes. Never-
theless, the similarity of the phenotypes in junction for-
mation and 3-D morphogenesis caused by depletion of
Apg-2 and ZO-1 suggests that the two interacting proteins
function in at least overlapping pathways during epithe-
lial differentiation.
Apg-2 depletion inhibits epithelial morphogenesis in 3-D culturesFigure 7
Apg-2 depletion inhibits epithelial morphogenesis in 3-D cultures. Control and Apg-2 RNAi cell lines were cultured 
as in figure 6. After fixation, the samples were labelled with FITC-phalloidin and antibodies against β-catenin (shown in red), the 
Golgi marker GP73 (shown in blue), and for DNA (shown in white). Panel B shows confocal sections taken at a higher magnifi-
cation than those in panel A. Note, cysts formed by Apg-2 depleted cells were often not normally polarised and had irregular 
shapes.Page 9 of 13
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Depletion of Apg-2 in MDCK cells retards junction assem-
bly and inhibits epithelial morphogenesis in three-dimen-
sional cultures, indicating that Apg-2 is a functionally
relevant regulator of epithelial differentiation.
Methods
Cell lines and culture conditions
Stable MDCK cell lines for conditional, tetracycline-
induced RNAi of Apg-2 and ZO-1, as well as control lines
were previously described [18,21]. For Apg-2, cell lines
expressing shRNAs targeting two different sequences were
used. For 3-D morphogenesis assays, the cells were plated
in a matrigel/collagen mix and cultured for 7 days as
detailed elsewhere [18]. For calcium switch assays, the
cells were trypsinised for 20 minutes, resuspended in nor-
mal DMEM with 10% fetal calf serum, and incubated at
room temperature for 15 minutes. The cells were then pel-
leted by centrifugation, resuspended in low calcium
medium (spinner culture medium, Sigma) with 10% dia-
lysed fetal calf serum, 2 mM L-glutamine and 1 mM
sodium pyruvate). The cells were centrifuged again and
resuspended in low calcium medium at a concentration of
1.5 × 106 cells/ml. 0.5 ml of this suspension was then
plated per tissue culture insert (12-well clusters, 0.4 µm
pore size, Corning). 1.5 ml of low calcium medium was
added to the outer chambers. After 18 hours, the low cal-
cium medium was replaced by standard tissue culture
medium (DMEM with 10% fetal calf serum) and TER
measurements were started after an initial incubation of
30 minutes at 37°C. For induction of RNAi, tetracycline
was added to the low calcium medium at time of plating.
Functional analysis of tight junctions
TER was measured at 37°C with an EVOM (World Preci-
sion Instruments) using an AC square wave current (+/-
20 mA, 12.5 Hz) and stick electrodes [40]. TER values for
individual cultures were calculated by subtracting the val-
ues measured for filters without cells. For paracellular dif-
fusion measurements, 4 kD FITC-dextran and 70 kD-
Rhodamine B dextran (Sigma) were dissolved in medium
and added to the apical chambers (1 mg/ml each) and dif-
fusion to the basolateral side of the two dextrans was then
assayed simultaneously as described [40]. Fluorescence
was determined with a FLUOstar Optima (BMG
LABTECH) plate reader (FITC-Dextran: Exc: 485 nm and
Em: 544 nm and/or Rhodamine B-Dextran: Exc: 520 nm
and Em: 590 nm).
Immunoblotting
At the end of calcium switch experiments and permeabil-
ity studies, filters were excised from their holders and
transferred into tubes containing 300 µl of SDS-PAGE
sample buffer. After separation on 5–15% gradient gels
and transfer to nitrocellulose, expression of specific pro-
teins was analysed by immunoblotting using the ECL
detection kit (Amersham) [41]. Rabbit polyclonal anti-
bodies specific for Apg-2, ZO-1, ZO-2, ZO-3 and mouse
monoclonal antibody against α-tubulin were previously
described [21,40,42,43].
Immunofluorescence
Cells were fixed with either methanol, or paraformalde-
hyde and then permeabilised with 0.3% Triton X-100 as
described [18,19,41]. Incubations with primary antibod-
ies, and FITC- and Cy3-conjugated secondary antibodies
(Jackson Immunochemicals, Inc.) as well as mounting of
samples were performed as previously described for 2-D
cultures [41] and 3-D cultures [18], respectively. Antibod-
ies against Apg-2, ZO-1, ZO-2, ZO-3, GEF-H1 and E-cad-
herin were previously described [21,40,42,44]. The Golgi
marker GP73 was labelled with an affinity purified rabbit
polyclonal antibody raised against a recombinant protein
containing the entire luminal domain. The antibodies
against the following antigens were obtained from com-
mercial sources: occludin, claudin-4, and cingulin,
Zymed, Inc.; α-catenin, Sigma; β-catenin and erbB-2,
Santa Cruz Biotechnology, Inc. The mouse anti-GP135/
podocalyxin antibody was kindly provided by Dr. G. Oja-
kian (SUNY Downstate Medical Center, Brooklyn, New
York, USA) [45]. Phase contrast and epifluorescence
images were obtained with a Leica DM1 RB microscope
Quantification of 3-D morphogenesis assaysFigure 8
Quantification of 3-D morphogenesis assays. Control 
and Apg-2 RNAi cell lines were cultured and processed as in 
figure 6. In two experiments performed with different 
batches of matrigel, pictures from ten different areas were 
taken and quantified by counting the number and types of 
cultures. The formed structures were divided into the fol-
lowing classes: spherical structures with a single lumen; 2 
lumen and 3 (or more lumen) but with a normal polarised 
organisation; and all other structures including cysts with no 
lumen.Page 10 of 13
(page number not for citation purposes)
BMC Cell Biology 2007, 8:49 http://www.biomedcentral.com/1471-2121/8/49equipped with a 63×/1.4 oil immersion objective and a
Hamamatsu ORCA285 camera. Confocal images were
acquired with eiher a Leica LCS SP2 or a BioRadiance2000
microscope also using a 63× oil immersion objectives.
The image acquisition software supplied by the manufac-
turers was used to collect the images. Image brightness
and contrast were adjusted with Adobe Photoshop.
Effect of Apg-2 and ZO-1 depletion on the organisation of 3-D culturesFigure 9
Effect of Apg-2 and ZO-1 depletion on the organisation of 3-D cultures. Control, and Apg-2 and ZO-1 RNAi cell 
lines were cultured as in figure 6. After fixation, the samples were labelled with antibodies against β-catenin and podocalyxin/
GP135 (A); occludin, erbB-2 and with Alexa654-phalloidin (B); or with TRITC-phalloidin and anti-ZO-1 antibodies (C). Note, 
erbB-2 does not only localise to the lateral plasma membrane but also to cytoplasmic organelles, causing the cytoplasmic stain-
ing between the nucleus in the apical membrane in control cultures (B). Residual ZO-1 staining in ZO-1 RNAi cells was 
detected at cell-cell contacts (C).Page 11 of 13
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